Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
Orly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.
Brain, Behavior, and Immunity
|
October 8, 2023
Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229]
Felicia Ceban, Dana Kulzhabayeva, Nelson B Rodrigues, et al.
Journal of Affective Disorders
|
May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
Yena Lee, Leanna M W Lui, David Chen-Li, et al.
Journal of Psychiatric Research
|
June 10, 2022
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi, David Chen-Li, Ella Krane, et al.
Harvard Review of Psychiatry
|
September 7, 2018
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
Roger S McIntyre, Yena Lee, Nicole E Carmona, et al.
Journal of Affective Disorders
|
July 31, 2021
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine
Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
Bipolar Disorders
|
May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder
Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research
|
June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Psychopharmacology
|
January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
Jason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
Scandinavian Journal of Pain
|
August 30, 2017
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)
Danielle S Cha, Nicole E Carmona, Rodrigo B Mansur, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series
Orly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.
Brain, Behavior, and Immunity
|
October 8, 2023
Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229]
Felicia Ceban, Dana Kulzhabayeva, Nelson B Rodrigues, et al.
Journal of Affective Disorders
|
May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
Yena Lee, Leanna M W Lui, David Chen-Li, et al.
Journal of Psychiatric Research
|
June 10, 2022
Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis
Yazen Alnefeesi, David Chen-Li, Ella Krane, et al.
Harvard Review of Psychiatry
|
September 7, 2018
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder
Roger S McIntyre, Yena Lee, Nicole E Carmona, et al.
Journal of Affective Disorders
|
July 31, 2021
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine
Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
Bipolar Disorders
|
May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder
Roger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research
|
June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?
Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Psychopharmacology
|
January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment
Jason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
Scandinavian Journal of Pain
|
August 30, 2017
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it)
Danielle S Cha, Nicole E Carmona, Rodrigo B Mansur, et al.
Page
of 7